Preimplantation Genetic Testing Market Research Report by Technology, Offering, Procedure Type, Application, End User, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19

The North America Preimplantation Genetic Testing Market size was estimated at USD 108.21 million in 2021 and expected to reach USD 116.94 million in 2022, and is projected to grow at a CAGR 9.99% to reach USD 191.68 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Preimplantation Genetic Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the market was studied across Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Next-Generation Sequencing, Polymerase Chain Reaction, and Single-Nucleotide Polymorphism.

Based on Offering, the market was studied across Instruments Services, Reagents and Consumables, and Software and Services.

Based on Procedure Type, the market was studied across Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening.

Based on Application, the market was studied across Aneuploidy, Gender Identification, HLA Typing, Single Gene Disorders, Structural Chromosomal Abnormalities, and X-Linked Disorders. The Structural Chromosomal Abnormalities is further studied across Deletions, Duplications, Inversions, and Translocations.

Based on End User, the market was studied across Contract Research and Manufacturing Organizations, Hospitals, Diagnostic Labs, and Service Providers, and Research Laboratories & Academic Institutes.

Based on Country, the market was studied across Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Preimplantation Genetic Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Preimplantation Genetic Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the North America Preimplantation Genetic Testing Market, including Abbott Laboratories, Agilent Technologies, Inc., EUROPE IVF International s.r.o., Genea Limited, Illumina, Inc., Invicta Genetics, Invitae Corporation, MedGenome Inc., Natera, Inc., Ovation Fertility, Oxford Gene Technology IP Limited, PacGenomics, PerkinElmer, Inc., Progenesis Fertility Center, Quest Diagnostics Incorporated, Reproductive Genetic Innovations, LLC, Takara Bio USA, Inc., The Cooper Companies Inc., Thermo Fisher Scientific Inc., and Yikon Genomics (Shanghai) Co., Ltd..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the North America Preimplantation Genetic Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the North America Preimplantation Genetic Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the North America Preimplantation Genetic Testing Market?
4. What is the competitive strategic window for opportunities in the North America Preimplantation Genetic Testing Market?
5. What are the technology trends and regulatory frameworks in the North America Preimplantation Genetic Testing Market?
6. What is the market share of the leading vendors in the North America Preimplantation Genetic Testing Market?
7. What modes and strategic moves are considered suitable for entering the North America Preimplantation Genetic Testing Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Preimplantation Genetic Testing Market, by Technology
6.1. Introduction
6.2. Comparative Genomic Hybridization
6.3. Fluorescence in Situ Hybridization
6.4. Next-Generation Sequencing
6.5. Polymerase Chain Reaction
6.6. Single-Nucleotide Polymorphism

7. Preimplantation Genetic Testing Market, by Offering
7.1. Introduction
7.2. Instruments Services
7.3. Reagents and Consumables
7.4. Software and Services

8. Preimplantation Genetic Testing Market, by Procedure Type
8.1. Introduction
8.2. Preimplantation Genetic Diagnosis
8.3. Preimplantation Genetic Screening

9. Preimplantation Genetic Testing Market, by Application
9.1. Introduction
9.2. Aneuploidy
9.3. Gender Identification
9.4. HLA Typing
9.5. Single Gene Disorders
9.6. Structural Chromosomal Abnormalities
9.7.1. Deletions
9.7.2. Duplications
9.7.3. Inversions
9.7.4. Translocations
9.7. X-Linked Disorders

10. Preimplantation Genetic Testing Market, by End User
10.1. Introduction
10.2. Contract Research and Manufacturing Organizations
10.3. Hospitals, Diagnostic Labs, and Service Providers
10.4. Research Laboratories & Academic Institutes

11. Canada Preimplantation Genetic Testing Market
11.1. Introduction

12. Mexico Preimplantation Genetic Testing Market
12.1. Introduction

13. United States Preimplantation Genetic Testing Market
13.1. Introduction

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Agilent Technologies, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. EUROPE IVF International s.r.o.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Genea Limited
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Illumina, Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Invicta Genetics
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Invitae Corporation
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. MedGenome Inc.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Natera, Inc.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Ovation Fertility
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Oxford Gene Technology IP Limited
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. PacGenomics
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. PerkinElmer, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Progenesis Fertility Center
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Quest Diagnostics Incorporated
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Reproductive Genetic Innovations, LLC
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Takara Bio USA, Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. The Cooper Companies Inc.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Thermo Fisher Scientific Inc.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Yikon Genomics (Shanghai) Co., Ltd.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing